167 results on '"Limberis, Maria P."'
Search Results
2. Immunosuppression reduces rAAV2.5T neutralizing antibodies that limit efficacy following repeat dosing to ferret lungs
3. Inhalation of SP-101 Followed by Inhaled Doxorubicin Results in Robust and Durable hCFTRΔR Transgene Expression in the Airways of Wild-Type and Cystic Fibrosis Ferrets.
4. SP-101, A Novel Adeno-Associated Virus Gene Therapy for the Treatment of Cystic Fibrosis, Mediates Functional Correction of Primary Human Airway Epithelia From Donors with Cystic Fibrosis.
5. Adeno-Associated Virus 9-Mediated Airway Expression of Antibody Protects Old and Immunodeficient Mice against Influenza Virus
6. In Vivo Evaluation of Adeno-Associated Virus Gene Transfer in Airways of Mice with Acute or Chronic Respiratory Infection
7. Restoring Ciliary Function: Gene Therapeutics for Primary Ciliary Dyskinesia
8. Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin
9. Adeno-Associated Virus Serotype 9-Expressed ZMapp in Mice Confers Protection Against Systemic and Airway-Acquired Ebola Virus Infection
10. Suppl Figs 4+5 from Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in Mice
11. Suppl Fig 3 from Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in Mice
12. Suppl Fig 8 from Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in Mice
13. Suppl Fig 7 from Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in Mice
14. Suppl Fig 2 from Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in Mice
15. Suppl Fig 6 from Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in Mice
16. Suppl Fig 1 from Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in Mice
17. Data from Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in Mice
18. Suppl Fig 9 from Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in Mice
19. Heart of the Matter: AAV8 Improves Cardiac Function
20. Gene Therapeutics for Surfactant Dysfunction Disorders: Targeting the Alveolar Type 2 Epithelial Cell
21. Adeno-Associated Virus Serotype 9 Vectors Transduce Murine Alveolar and Nasal Epithelia and Can Be Readministered
22. Adeno-Associated Virus Vector-Mediated Expression of Antirespiratory Syncytial Virus Antibody Prevents Infection in Mouse Airways
23. Preclinical Development of a HIV-Based Gene Therapeutic for Cystic Fibrosis Pulmonary Disease
24. The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice
25. Cystic fibrosis: recent advances in lung-directed therapies
26. HC[O.sub.3.sup.-] secretion by murine nasal submucosal gland serous acinar cells during [Ca.sup.2+]-stimulated fluid secretion
27. An optimized protocol for detection of E. coli β-galactosidase in lung tissue following gene transfer
28. Breathing Easier: Molecular Therapeutics for Cystic Fibrosis
29. Evaluation of Virus‐based Vectors for Cystic Fibrosis Gene Therapy
30. Optical imaging of Ca2+-evoked fluid secretion by murine nasal submucosal gland serous acinar cells
31. Prediction of Cellular Immune Responses against CFTR in Patients with Cystic Fibrosis after Gene Therapy
32. Adeno-associated virus-mediated expression of human butyrylcholinesterase to treat organophosphate poisoning
33. Intrathecal Viral Vector Delivery of Trastuzumab Prevents or Inhibits Tumor Growth of Human HER2-Positive Xenografts in Mice
34. Preparation of Nonhuman Primate Eyes for Histological Evaluation After Retinal Gene Transfer
35. A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis
36. Nonclinical Pharmacology/Toxicology Study of AAV8.TBG.mLDLR and AAV8.TBG.hLDLR in a Mouse Model of Homozygous Familial Hypercholesterolemia
37. Non-Clinical Study Examining AAV8.TBG.hLDLR Vector-Associated Toxicity in Chow-Fed Wild-Type and LDLR+/−Rhesus Macaques
38. Vector serotype screening for use in ovine perinatal lung gene therapy
39. 695. An AAV8 Mutant with Better Transduction in Murine Muscle and Nasal Airway Than AAV8
40. 699. Effective AAV9 Vector Delivery to Nasal Mucosa for Protection Against Airborne Challenge with Influenza A and B
41. Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
42. In VivoEvaluation of Adeno-Associated Virus Gene Transfer in Airways of Mice with Acute or Chronic Respiratory Infection
43. Adeno-Associated Virus 9-Mediated Airway Expression of Antibody Protects Old and Immunodeficient Mice against Influenza Virus
44. In Utero Lung Gene Transfer Using Adeno-Associated Viral and Lentiviral Vectors in Mice
45. Vectored Expression of the Broadly Neutralizing Antibody FI6 in Mouse Airway Provides Partial Protection against a New Avian Influenza A Virus, H7N9
46. Biodistribution of AAV8 Vectors Expressing Human Low-Density Lipoprotein Receptor in a Mouse Model of Homozygous Familial Hypercholesterolemia
47. Self-Reactive CFTR T Cells in Humans: Implications for Gene Therapy
48. Intranasal Antibody Gene Transfer in Mice and Ferrets Elicits Broad Protection Against Pandemic Influenza
49. RPGR-Associated Retinal Degeneration in Human X-Linked RP and a Murine Model
50. Phoenix rising: gene therapy makes a comeback
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.